chrysin and Neurodegenerative-Diseases

chrysin has been researched along with Neurodegenerative-Diseases* in 3 studies

Reviews

2 review(s) available for chrysin and Neurodegenerative-Diseases

ArticleYear
Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent.
    Nutrients, 2021, Jun-14, Volume: 13, Issue:6

    Chrysin belongs to the group of natural polyphenols. It can be found, among others, in honey, propolis and fruits and has a wide range of biological activities, including the prevention of oxidative stress, inflammation, neurodegeneration and carcinogenesis. Being a part of the human diet, chrysin is considered to be a promising compound to be used in the prevention of many diseases, including cancers, diabetes and neurodegenerative diseases such as Alzheimer's or Parkinson's. Nevertheless, due to the low solubility of chrysin in water and under physiological conditions, its bioavailability is low. For this reason, attempts at its functionalization have been undertaken, aiming to increase its absorption and thus augment its in vivo therapeutic efficacy. The aim of this review is to summarize the most recent research on chrysin, including its sources, metabolism, pro-health effects and the effects of its functionalization on biological activity and pharmacological efficacy, evaluated both in vitro and in vivo.

    Topics: Animals; Antineoplastic Agents; Biological Availability; Drug Carriers; Eye Diseases; Flavonoids; Humans; Inflammation; Liver; Neoplasms; Neurodegenerative Diseases; Neuroprotection; Polyphenols; Skin Diseases

2021
Neuroprotective effects of chrysin: From chemistry to medicine.
    Neurochemistry international, 2015, Volume: 90

    The World Health Organization estimated that the proportion of older people (over 60 years) will increase from 11% to 22% during next 40 years throughout the world. With respect to this, the morbidity and mortality rates of age-related diseases will increase. Mental diseases are the most common and important health problems among elderly people. Therefore, much attention has been paid to the discovery of neuroprotective drugs with high efficacy and negligible adverse effects. A growing body of scientific evidence has shown that phytochemicals possess neuroprotective effects and also mitigate neurodegeneration under both in vivo and in vitro conditions. Polyphenolic compounds, especially flavonoids, are known as most common chemical class of phytochemicals which possess a multiple range of health promoting effects. Chrysin, belonging to the flavone class, is one of the most important bioactive constituents of different fruits, vegetables and even mushrooms. Chrysin possesses potent neuroprotective effects and suppress neuroinflammation. In addition, chrysin improves cognitive decline and possesses a potent anti-amyloidogenic and neurotrophic effects. Furthermore, beneficial effects of chrysin on both depression and epilepsy have been reported. The present paper aimed to critically review the available literature data regarding the neuroprotective effects of chrysin as well as its chemistry, sources and bioavailability.

    Topics: Animals; Antioxidants; Flavonoids; Humans; Mental Disorders; Neurodegenerative Diseases; Neuroprotective Agents; Tumor Necrosis Factor-alpha

2015

Other Studies

1 other study(ies) available for chrysin and Neurodegenerative-Diseases

ArticleYear
Chrysin-Loaded Chitosan Nanoparticle-Mediated Neuroprotection in Aβ
    ACS chemical neuroscience, 2022, 07-06, Volume: 13, Issue:13

    Amyloid β plaques and neurofibrillary tangles are the characteristic features of Alzheimer's disease (AD). Plaques of amyloid β play a pivotal role in affecting cognitive functions and memory. Alzheimer's disease is a progressive neurodegenerative disease and is one of the leading causes of dementia worldwide. Several treatment strategies focusing on the amyloid cascade have been implemented to treat AD. The blood-brain barrier (BBB) poses the main obstructive barrier by refraining drugs from penetrating the brain. Nanotechnology is a promising research field for brain drug delivery using nanosized particles. Zebrafish is emerging as a model of interest to elaborate on brain targeting and nanotechnology-based therapeutics for neurodegenerative diseases. In the current study, we have synthesized and characterized chrysin-loaded chitosan nanoparticles (Chr-Chi NPs) and evaluated them for neuroprotection against amyloid-β-induced toxicity. We find that treatment with Chr-Chi NPs helps to retain memory, cognition, and synaptic connections, which are otherwise compromised due to Aβ

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Chitosan; Flavonoids; Nanoparticles; Neurodegenerative Diseases; Neuroprotection; Peptide Fragments; Plaque, Amyloid; Zebrafish

2022